Previous Article | Next Article ![]()
Journal of Virology, March 2001, p. 2067-2075, Vol. 75, No. 5
Department of Microbiology, Michigan State
University, East Lansing, Michigan 48824-1101
Received 19 June 2000/Accepted 6 November 2000
The various alphaherpesviruses, including Marek's disease virus
(MDV), have both common and unique features of gene content and
expression. The entire MDV Us region has been sequenced in our laboratory (P. Brunovskis and L. F. Velicar, Virology
206:324-338, 1995). Genes encoding the MDV glycoprotein D (gD),
glycoprotein I (gI), and glycoprotein E (gE) homologs have been found
in this region, although no gG homolog was found. In this work,
transcription of the tandem MDV gD, gI, and gE genes was studied and
found to have both unique characteristics and also features in common
with other alphaherpesviruses. MDV gD could not be immunoprecipitated from MDV GA-infected duck embryo fibroblast cells by antisera reactive
to its TrpE fusion proteins, while gI and gE could be. When the gD gene
was subjected to in vitro-coupled transcription-translation, the
precursor polypeptide was produced and could be immunoprecipitated by
anti-gD. Northern blot, reverse transcriptase PCR, and RNase protection
analyses have shown that (i) no mRNA initiating directly from the gD
gene could be detected; (ii) a large but low-abundance 7.5-kb
transcript spanning five genes, including the one encoding gD, was seen
on longer exposure; and (iii) transcription of the gI and gE genes
formed an abundant bicistronic 3.5-kb mRNA, as well as an abundant
2.0-kb gE-specific mRNA. Therefore, the MDV gD gene expression is
down-regulated at the transcription level in MDV-infected cell culture,
which may be related to the cell-associated nature of MDV in fibroblast
cells. Compared to the highly gD-dependent herpes simplex virus and the
other extreme of the varicella-zoster virus which lacks the gD gene,
MDV is an intermediate type of alphaherpesvirus.
Marek's disease virus (MDV) is a
highly infectious herpesvirus which induces lymphomas in chickens. The
nonpathogenic and antigenically related herpesvirus of turkey (HVT) is
usually effective as a vaccine against Marek's disease and is the
first successful vaccine against a naturally occurring tumor of any
species. While being a very interesting and valuable natural host
animal model for oncogenesis, this cell-associated herpesvirus system
is somewhat complex. Fully enveloped infectious virions are produced
only in feather follicle epithelium (FFE) of the skin; they then detach with feather dander, contaminate dust, are spread by the airborne route, and infect new hosts via the respiratory tract. Four phases of
infection in vivo can be delineated: (i) early productive-restrictive virus infection causing primarily degenerative changes, (ii) latent infection, (iii) a second phase of cytolytic infection coincident with
permanent immunosuppression, and (iv) a proliferative phase involving
nonproductively infected lymphoid cells that may progress to the point
of lymphoma formation (5).
MDV and HVT have genome structures closely resembling those of
alphaherpesviruses such as herpes simplex virus type 1 (HSV-1), the
prototype alphaherpesvirus, varicella-zoster virus (VZV), pseudorabies
virus (PRV), bovine herpesvirus 1 (BHV-1), and equine herpesvirus 1. The alphaherpesvirus genome structure consists of covalently joined
long (L) and short (S) components. The S component comprises a unique
short (Us) segment flanked by a pair of inverted repeat
regions. There are four glycoprotein genes in the HSV-1 Us
region, encoding glycoproteins G (gG), D (gD), I (gI), and E (gE)
(10).
HSV-1 gD is a virion envelope component which plays an essential role
in HSV-1 entry into susceptible mammalian cells (15). HSV-1 gD has been implicated in receptor binding, cell fusion, and
neuroinvasiveness (11). Immunization of animals with HSV-1 gD stimulates the production of virus-neutralizing antibodies and
protects them from both lethal challenge with HSV-1 and the establishment of latency (4). Homologs of HSV-1 gD have
been identified in the genomes of PRV and BHV-1, among other
alphaherpesviruses. The gDs of HSV-1, PRV, and BHV-1 cause viral
interference (7, 16, 27). Although the gD homolog of PRV
is essential for penetration, its production is not required for
cell-to-cell spread (26).
The gI and gE homologs of HSV-1, PRV, and VZV are found to form
complexes. HSV-1 gE and VZV gE act as immunoglobulin G Fc receptors
that may utilize an antibody bipolar bridging mechanism to protect
virus-infected cells from antibody-dependent cellular cytotoxicity
(14, 20). HSV-1 and PRV gE are involved in neurotropism and virulence during virus infection of animals (6, 23).
The entire MDV Us region has been sequenced in our
laboratory (3). Genes encoding the MDV gD, gI, and gE
homologs have been found in this region, although no gG homolog was
found. Antisera to their TrpE fusion proteins have been produced (see
Fig. 1). MDV gI and gE have been identified in MDV-infected cells by
immunoprecipitation with their respective antisera (2). In
contrast, no gD was found in MDV-infected cells with antisera to its
TrpE fusion proteins (2).
In this study, antiserum to TrpE-gD was used in a further attempt to
detect MDV gD expression in MDV-infected cells, but no protein of the
predicted size was found. When Northern blot, reverse transcriptase PCR
(RT-PCR) and RNase protection analyses were performed, an abundant
3.5-kb bicistronic mRNA including the MDV gI and gE genes was detected,
together with an abundant 2.0-kb monocistronic transcript specific for
the gE gene. In contrast, there was no specific mRNA initiating from
the gD gene promoter, although a low-abundance polycistronic mRNA
including the MDV US3, SORF4, gD, gI, and gE genes was found.
(Preliminary results of this work were presented at the 1996 International Symposium on Marek's Disease.)
Cells and viruses.
The preparation, propagation, and
infection of duck embryo fibroblast (DEF) and chicken embryo fibroblast
(CEF) cells with cell-associated MDV were performed as described
previously (8). The virulent MDV GA strain used in this
study was at cell culture passage level 6 following isolation of
cell-free virus from feather tips obtained from infected birds with
symptoms of Marek's disease.
Generation of TrpE fusion proteins and antibodies to fusion
proteins.
The vector system used to express the MDV genes in
Escherichia coli consists of a group of plasmids (pATH
vectors) encoding approximately 37 kDa of the bacterial TrpE open
reading frame (ORF) product under control of the inducible
trp operon promoter. A polylinker with multiple cloning
sites at the 3' end of the trpE ORF allows in-frame
insertion of foreign ORFs. The TrpE fusion proteins were generated as
described previously (8). The fusion proteins were
purified from preparative sodium dodecyl sulfate (SDS)-7.5%
polyacrylamide gels and used to prepare antisera by injecting rabbits
as described previously (8).
In vitro transcription and translation.
MDV SORF4, gD, gI,
and gE genes were cloned downstream of T3 or T7 promoters. In
vitro-coupled transcription-translation was performed with Promega's
TNT coupled reticulocyte lysate system.
Radiolabeling of proteins and immunoprecipitation analysis.
MDV-infected and mock-infected control DEF cells were labeled with
[35S]methionine at 72 h postinfection for 4 h. After
labeling was complete, culture medium samples and cell lysates were
prepared and immunoprecipitation analysis was carried out as previously described (8). Briefly, 400 µl of
35S-labeled cell lysates were pretreated with normal rabbit
serum for 2 h, protein A was added, and the mixture was incubated
for 1 h and centrifuged. After centrifugation, the supernatants
were mixed with the respective antisera for 2 h. Then protein
A-Sepharose was added, and the suspension was incubated with gentle
mixing for 2 h, followed by centrifugation. Immunoprecipitates
were resuspended in sample buffer, recentrifuged, and subjected to
SDS-polyacrylamide gel electrophoresis (PAGE). Protein markers (GIBCO)
were used as molecular weight standards.
RNA preparation, isolation, and Northern blot analysis.
RNAs
were prepared from MDV-infected and mock-infected control cells at
72 h postinfection by the guanidinium isothiocyanate-phenol extraction procedure. Poly(A)+ RNAs were prepared by
oligo(dT) cellulose spin columns. Northern blot analysis was performed
as described previously (29). DNA probes were labeled by
the random-priming method. Riboprobes were prepared as described below.
Transcript size determinations were based on a comparison with a GIBCO
RNA ladder run in parallel.
Riboprobe and RNA marker preparation.
Antisense riboprobes
and RNA marker were generated by in vitro transcription off linearized
plasmid templates with RNA polymerase T3 or T7 (Promega). For
riboprobes and RNA markers used in RNase protection, the 20-µl
reaction solution included 5 mM each GTP, ATP, and CTP, in addition to
4.5 µl of [
0022-538X/01/$04.00+0 DOI: 10.1128/JVI.75.5.2067-2075.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Transcriptional Analysis of Marek's Disease Virus
Glycoprotein D, I, and E Genes: gD Expression Is Undetectable in
Cell Culture
and
![]()
ABSTRACT
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
![]()
INTRODUCTION
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
![]()
MATERIALS AND METHODS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
-32P]UTP (800 µCi/mmol). For riboprobes
used in Northern blot analysis, 50 µM unlabeled UTP was added to the
reaction mixture.
RNase protection analysis. A 500,000-cpm portion of a riboprobe was hybridized with 40 µg of total RNA in 20 µl of hybridization buffer (40 mM PIPES [pH6.4], 1 mM EDTA, 0.4 M NaCl, 80% formamide) and incubated at 42°C overnight. The hybridization solution was diluted with 300 µl of digestion buffer (300 mM NaCl, 10 mM Tris-HCl [pH7.5], 5 mM EDTA, 40 µg of RNase A per ml, 800 U of RNase T1 per ml) and incubated at 30°C for 60 min. After digestion, the samples were extracted with phenol-chloroform and the RNAs were precipitated in ethanol. The pellets were then resuspended in loading buffer and subjected to electrophoresis on a polyacrylamide-urea sequencing gel.
RT-PCR assays. Total RNA preparations were treated with RNase-free DNase I (10 U per mg of total RNA) for 30 min at 37°C. Reverse transcription was performed with Superscript II RT (GIBCO) using the oligo(dT) primer. This reaction mixture (1/10 aliquot) was subjected to 30 cycles of PCR consisting of 94°C for 1 min, 50°C for 2 min, and 72°C for 3 min. The product (1/10 aliquot) was loaded onto agarose gels for electrophoresis, and DNA was visualized with ethidium bromide. Nucleotide positions of the primers are shown in Fig. 5A. Primer D sense (DS) (5' TACGTGAATATGCCAACTGC 3') corresponded to nucleotide positions 7340 to 7359. Primer D antisense (DA) (5' AGTGAGTCCAGTGTAACCATCC 3') corresponded to nucleotide positions 7875 to 7896. Primer I sense (IS) (5' TGGTATATGCTCAACCTCATGG 3') corresponded to nucleotide positions 8574 to 8595. Primer I antisense (IA) (5' ACCGATGTATATCCTACGATGG 3') corresponded to nucleotide positions 8574 to 8595. Primer E sense (ES) (5' GAATCGCTAAGTCTGAATGG 3') corresponded to nucleotide positions 9791 to 9800. Primer E antisense (EA) (5' CAGAATGTCAATGTTGGATGCG 3') corresponded to nucleotide positions 10249 to 10270.
| |
RESULTS |
|---|
|
|
|---|
Immunoprecipitation analysis fails to detect MDV gD in MDV-infected
cell culture.
Of the 11 MDV Us genes, 7 are HSV-1
homologs: US1, US10, US2, US3, US6, (gD), US7 (gI), and US8 (gE).
Fragments from each gene have been cloned in-frame with trpE
to make TrpE fusion proteins (Fig. 1).
Antisera to each TrpE fusion protein have been produced. With these
antisera, the proteins encoded by MDV US1, US10, US2, US3, US7 (gI),
and US8 (gE) have been identified in extracts from MDV-infected DEF
cells, but no gD (US6) protein was found (2).
|
|
The MDV gD gene encodes a functional protein.
Failure to
detect gD expression could result from a defective ORF; the presumed gD
ORF may not encode an authentic protein. To address this question, the
MDV gD gene, as well as the SORF4, gI, and gE genes as controls, was
cloned downstream of T3 or T7 promoters, and in vitro coupled
transcription-translation was performed with T3 or T7 RNA polymerases
and rabbit reticulocyte lysate (Promega). Each of the SORF4, gD, gI,
and gE genes was transcribed and translated into a precursor
polypeptide (Fig. 3A). The gD precursor
polypeptide was about 43 kDa, close to the mass predicted from its
amino acid sequence.
|
Northern blot analysis of mRNA from MDV-infected cells using DNA probes. Like other alphaherpesvirus homologs, the MDV gD (US6), gI (US7), and gE (US8) genes are clustered in that order within the unique short region of the viral genome, spanning nucleotides 6943 to 10960 (Fig. 1) (3). One poly(A) terminator sequence, AATAAA, is located upstream of US6 (gD), and another AATAAA sequence is located downstream of US8 (gE). There is no such sequence downstream of US6 (gD) or US7 (gI). In eucaryotic systems, the protein is most probably translated from the first favorable ATG of an mRNA. Therefore, for efficient expression of the MDV gD or gI genes, mRNA which starts just upstream of the gD gene or the gI gene should exist. However, if MDV gD expression is down-regulated at the transcription level, the gD-specific transcript may not be detectable.
To characterize transcripts of the MDV gD, gI, and gE genes, Northern blot analysis was done with mRNA from MDV GA-infected DEF cells, with RNA from mock-infected DEF cells used as a negative control. Fragments of each of the genes, which had previously been used to make the TrpE fusion protein, were used to make double-stranded DNA probes for Northern blot analysis. The gD probe included nucleotides 7398 to 7797 from US6 (gD), the gI probe included nucleotides 8374 to 8804 from US7 (gI), and the gE probe included nucleotides 9773 to 10574 from US8 (gE) (Fig. 1). The gD probe did not hybridize with any abundant mRNA (Fig. 4, lane 2), which may account for the failure to detect the MDV gD protein by immunoprecipitation. The gI probe hybridized with an abundant 3.5-kb mRNA that was also detected by the gE probe. In addition, the gE probe hybridized with another 2.0-kb transcript, which may be 3'-coterminal with the 3.5-kb transcript. When the blots were subjected to overexposure, a low-abundance large fragment of about 7.5 kb was barely detected by the gD, gI, and gE probes (data not shown). Thus, an explanation of the 7.5-kb fragment requires further study.
|
RT-PCR analysis of the MDV gD, gI, and gE transcripts.
To
confirm the existence of a low-abundance polycistronic transcript that
includes the gD gene, RT-PCR was performed with DNase I-treated total
RNA from MDV-infected DEF cells. First-strand cDNA was synthesized in
the reverse transcription reaction, and this was followed by PCR. In
the control experiment, the same procedure was performed, except that
no RT was added in the cDNA synthesis step. The primers from the gD
gene are designated DS (D sense) and DA (D antisense), the primers from
the gI gene are designated IS and IA, and the primers from the gE gene
are designated ES and EA (Fig. 5A).
|
Northern blot analysis of mRNA from MDV-infected cells using riboprobes. To further characterize the low-abundance large transcript, a more sensitive Northern blot analysis was performed with riboprobes and a larger amount of mRNA. MDV-infected CEF cells were used instead of DEF cells in this experiment to determine if the transcription pattern was different between these two cell culture systems.
In the MDV Us region, the SORF3 and US2 genes are leftward oriented while the US3, SORF4, gD, gI, and gE genes are rightward oriented (Fig. 1) (3). DNA fragments including each gene were cloned between the T7 and T3 promoters so that riboprobes could be synthesized. All of the riboprobes were generated as leftward oriented. Thus, they were in antiparallel to the US3, SORF4, gD, gI, and gE genes but parallel to the US2 and SORF3 genes. The US2 probe included nucleotides 3747 to 4837, the US3 probe included nucleotides 4865 to 6269, the SORF4 probe included nucleotides 6334 to 6922, the gD probe included nucleotides 6943 to 8157, the gI probe included nucleotides 8195 to 9354, and the gE probe included nucleotides 9443 to 10973. Because riboprobes are much more sensitive than DNA probes and because four times more mRNA was used in these experiments than in the previous Northern blot analysis with DNA probes, the low-abundance 7.5-kb transcript was now more readily detected and analyzed (Fig. 6A, lane 8). Comparing this Northern blot experiment with the previous one, both the gI-gE bicistronic 3.5-kb transcript and the gE-specific 2.0-kb transcript were detected (Fig. 4 and 6A), as expected. A less abundant gE-specific 4.4-kb transcript was also detected by this more sensitive method (Fig. 6B, lane 12). However, after 12 h of exposure the same blot clearly showed only the very abundant 3.5- and 2.0-kb transcripts (data not shown). The low-abundance species would appear to have little significance in the synthesis of gE. Thus, the transcription pattern is very similar between the MDV-infected -CEF cells and DEF cells.
|
RNase protection analysis of the MDV gI and gE transcripts.
In
contrast to the gD gene, the gI and gE genes are transcribed
efficiently in MDV-infected cells. To confirm the lack of a gD promoter
and to determine the promoter regions and 3' termini of the gI and gE
transcripts, RNase protection analysis was performed. A series of
subgenomic fragments inclusive of ATG sites or AATAAA sequences were
subcloned into pBCSK(+) plasmids. A series of riboprobes complementary
to mRNA were generated (Fig. 7A),
hybridized to RNA obtained from mock-infected and MDV-infected cells
72 h postinfection, digested with RNase, and analyzed on
sequencing gels. The size of each fragment was calculated based on a
comparison with the synthesized RNA marker. No gD gene-specific
promoter region could be detected by this method (data not shown).
|
|
| |
DISCUSSION |
|---|
|
|
|---|
This study confirmed that MDV gD expression is below the limit of detection in MDV-infected cell culture and showed that this is because of inefficient gD gene-specific transcription. The only transcript clearly detected by the gD gene probe initiates two ORFs upstream of the gD gene. Research on HSV-1 has revealed that each viral gene has its own promoter and that each transcript contains a single functional ORF. Although some HSV-1 mRNAs contain additional protein-coding sequences downstream of their primary ORFs, proteins are not translated from these downstream regions. Instead, abundant proteins are translated from the mRNAs initiating immediately 5' to their genes (22), consistent with the overwhelmingly monocistronic nature of eukaryotic genes. Thus, a priori, the possibility of significant gD gene translation from the 7.5-kb transcript is very unlikely.
HSV-1 gD gene transcription initiates about 85 nucleotides upstream of its ATG codon. Two TATA motifs are located 108 and 126 nucleotides 5' to the ATG codon. Furthermore, DNA within the 168 nucleotides upstream is required for regulated expression of the HSV-1 gD gene, and the consensus ICP4 binding motif ATCGTC is found in this region (21). In the upstream region of the MDV gD gene, three TATA motifs are located at 27, 36, and 50 nucleotides 5' to the ATG codon. No ICP4 binding motif is found there. A consensus poly(A) signal AATAAA sequence is located 60 nucleotides 5' to the gD start codon, which is very close to the TATA motifs. The proximity of the AATAAA sequence may destabilize the transcription initiation complex formed on the TATA sequences and abort the transcription initiation from the gD gene.
MDV gI gene transcription is initiated 23 nucleotides 5' to its ATG site, in contrast to its homolog, the HSV-1 gI transcript, which is initiated 91 nucleotides 5' to its ATG site. Similarly, the MDV gE untranslated region is 24 bases long, only one-third the length of its HSV-1 homolog (73 bases). Considering that the region between MDV gD and gI genes and the region between the gI and gE genes are much shorter than the corresponding regions among the HSV-1 gD, gI, and gE genes, the relatively shorter untranslated regions of MDV gI and gE transcripts are expected.
Either the TATATA sequence or the TATAG sequence upstream of the gI gene CAP site may serve as the TATA box for transcription initiation. Similarly, the TATAT sequence, the TTTAAA sequence, or the TATAA sequence upstream of the gE initiation site may serve as the TATA box for gE transcription initiation. Since the 5' termini of the gI and gE transcripts have been mapped by the RNase protection assay, their promoter regions have been identified and can be studied. The VZV gpIV (gI homolog) promoter has a very low basal level of transcription, but viral factors or virus-induced factors can significantly activate its promoter activity (19). Whether the MDV gI and gE promoters share similar features remains to be determined.
The 2.0- and 3.5-kb transcripts of gI and gE appear to coterminate at a typical AATAAA motif. It is very common among alphaherpesvirus transcription that one polyadenylation signal is shared by several genes, each initiating from its own promoter (17, 22). Two possible 3' termini of the gI and gE transcripts were identified in the RNase protection assay. Heterogeneous 3' ends have been described previously for the VZV gpIV (gI homolog) transcript (19). It is very likely that both the 2.0-kb and 3.5-kb transcripts can terminate at either site.
Because Fig. 6 is a composite made up from the development of 12 different films, those that had been fixed somewhat longer have a darker background (Fig. 6A lanes 7 and 8; Fig. 6B, lanes 1, 2, 9, and 10). Longer exposure of the Northern blot showed several very low abundance fragments smaller than the low-abundance 7.5-kb transcript (Fig. 6B, lanes 4, 6, and 8). These signals may represent nonspecifically hybridized RNA or may represent transcripts present in extremely low abundance. Translation from these uncharacterized transcripts and leaky scanning translation from the 7.5-kb transcript may be able to produce very few gD molecules. Nonetheless, even if these rare translations take place, the few gD molecules could play no significant role in MDV infection. This notion is supported by a study by Morgan's group in which an MDV gD lacZ insertion mutant was made which had similar growth kinetics to the wild-type MDV in both cell culture and chickens (1, 25).
Among the other alphaherpesviruses, HSV-1 has an essential gD gene; VZV, a highly cell-associated virus, lacks a gD homolog altogether; and PRV and BHV-1 are cell-free viruses, but their gD mutants become cell associated, although their infectivity is greatly impaired (12, 18, 28). In keeping with these observations, MDV, a highly cell-associated virus in cell culture, lacks detectable gD expression in cell culture. The FFE of MDV-infected chickens is the only known tissue producing cell-free virus, and whether MDV gD is expressed there is a very interesting question. To address this question, other groups have made monoclonal antibody and detected MDV-gD expression in a few feather follicles (24).
Whether the MDV gD expression phenomenon (perhaps limited only to a few FFE cells) is unique to gD or whether other MDV genes also exhibit this pattern needs to be characterized, and related mechanisms need to be further explored. Learning from research on HSV-1, we can assume that there are specific cellular receptors for MDV. However, since currently known HSV-1 receptors bind to gD, the receptors for MDV probably are of a different type or react with a different viral protein.
| |
ACKNOWLEDGMENTS |
|---|
This research was supported by the State of Michigan Research Excellence Fund, through Michigan State University's Center for Animal Production Enhancement, and by the Cooperative State Research Service, U.S. Department of Agriculture, under Agreement 90-37266-5589.
We thank Ruth A. Vrable for excellent technical assistance. The critical reading of the manuscript by Bill MacCarthur, Robert Silva, Masahiro Niikura, and Calvin Keeler is appreciated. X.T. also thanks guidance committee members Paul Coussens, Don Salter, Roger Maes, and Richard Schwartz for careful reviews of the manuscript and many helpful suggestions.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Department of Animal and Food Sciences, University of Delaware, Newark, DE 19717-1303. Phone: (302) 831-8794. Fax: (302) 831-2822. E-mail: tanxinyu{at}udel.edu.
Dedicated to the memory of Leland F. Velicer, who passed away on 27 December 2000.
Present address: Department of Molecular and Microbiology, Case
Western Reserve University, Cleveland, OH 44106-4960.
§ Deceased.
| |
REFERENCES |
|---|
|
|
|---|
| 1. |
Anderson, A. S.,
M. S. Parcells, and R. W. Morgan.
1998.
The glycoprotein D (US6) homolog is not essential for oncogenicity or horizontal transmission of Marek's disease virus.
J. Virol.
72:2548-2553 |
| 2. | Brunovskis, P., X. Chen, and L. F. Velicer. 1992. Analysis of Marek's disease virus glycoproteins D, I and E, p. 118-122. In Proceedings of the 19th World's Poultry Congress, vol. 1. 4th International Symposium on Marek's Disease. Part Posen and Looijen, Wageningen, The Netherlands. |
| 3. | Brunovskis, P., and L. F. Velicer. 1995. The Marek's disease virus (MDV) unique short region: alphaherpesvirus-homologous, fowlpox virus-homologous, and MDV-specific genes. Virology 206:324-338[CrossRef][Medline]. |
| 4. | Burke, R. L. 1993. HSV vaccine development, p. 367-380. In B. Roizman, and C. Lopez (ed.), The herpesviruses. Raven Press, New York, N.Y. |
| 5. | Calnek, B. W., and R. L. Witter. 1991. Marek's disease, p. 342-385. In B. W. Calnek (ed.), Diseases of poultry. Iowa State University Press, Ames. |
| 6. |
Card, J. P.,
M. E. Whealy,
A. K. Robbins, and L. W. Enquist.
1992.
Pseudorabies virus envelope glycoprotein gI influences both neurotropism and virulence during infection of the rat visual system.
J. Virol.
66:3032-3041 |
| 7. |
Chase, C. C. L.,
K. Carter-Allen,
C. Lohff, and G. Letchworth, III.
1990.
Bovine cells expressing bovine herpesvirus 1 glycoprotein IV resist infection by BHV-1, herpes simplex virus, and pseudorabies virus.
J. Virol.
64:4866-4872 |
| 8. |
Chen, X., and L. F. Velicer.
1992.
Expression of the Marek's disease virus homolog of herpes simplex virus glycoprotein B in Escherichia coli and its identification as B antigen.
J. Virol.
66:4390-4398 |
| 9. | Cui, Z., Y. You, and L. F. Lee. 1992. Identification and localization of the Marek's disease virus group-common antigen p79 gene, p. 89-92. In Proceedings of the 19th World's Poultry Congress, vol. 1. 4th International Symposium on Marek's Disease. Part, Pasen and Luoijen, Wageningen, The Netherlands. |
| 10. | Davison, A. J. (ed.). 1993. HSV and other alphaherpesviruses. Semin. Virol. 4. |
| 11. |
Fuller, A. O., and W.-C. Lee.
1992.
Herpes simplex virus type 1 entry through a cascade of virus-cell interactions requires different roles of gD and gH in penetration.
J. Virol.
66:5002-5012 |
| 12. |
Heffner, S.,
F. Kovacs,
B. G. Klupp, and T. C. Mettenleiter.
1993.
Glycoprotein gp50-negative pseudorabies virus: a novel approach toward a nonspreading live herpesvirus vaccine.
J. Virol.
67:1529-1537 |
| 13. |
Isfort, R. J.,
I. Sithole,
H. Kung, and L. F. Velicer.
1986.
Molecular characterization of Marek's disease herpesvirus B antigen.
J. Virol.
59:411-419 |
| 14. |
Johnson, D. C.,
M. C. Frame,
M. W. Ligas,
A. M. Cross, and N. G. Stow.
1988.
Herpes simplex virus immunoglobulin G Fc receptor activity depends on a complex of two viral glycoproteins, gE and gI.
J. Virol.
62:1347-1354 |
| 15. |
Johnson, D. C., and M. W. Ligas.
1988.
Herpes simplex viruses lacking glycoprotein D are unable to inhibit virus penetration: quantitative evidence for virus-specific cell surface receptors.
J. Virol.
62:4605-4612 |
| 16. |
Johnson, R. M., and P. G. Spear.
1989.
Herpes simplex virus glycoprotein D mediates interference with herpes simplex virus infection.
J. Virol.
63:819-827 |
| 17. |
Kinchington, P. R.,
J. Vergnes,
P. Defechereux,
J. Piette, and S. E. Turse.
1994.
Transcriptional mapping of the varicella-zoster virus regulatory genes encoding open reading frames 4 and 63.
J. Virol.
68:3570-3581 |
| 18. | Liang, X., C. Pyne, Y. Li, L. A. Babiuk, and J. Kowalski. 1995. Delineation of the essential function of bovine herpesvirus 1 gD: an indication for the modulatory role of gD in virus entry. Virology 207:429-441[CrossRef][Medline]. |
| 19. |
Ling, P.,
P. R. Kimchington,
M. Sadeghi-zadeh,
W. T. Ruyechan, and J. Hay.
1992.
Transcription from varicella-zoster virus gene 67 (glycoprotein IV).
J. Virol.
66:3690-3698 |
| 20. |
Litwin, V.,
W. Jackson, and C. Grose.
1992.
Receptor property of two varicella-zoster virus glycoproteins gpI and gpIV homologous to herpes simplex virus gE and gI.
J. Virol.
66:3643-3651 |
| 21. | McGeoch, D. J., A. Dolan, S. Donald, and F. J. Rixon. 1985. Sequence determination and genetic content of the short unique region in the genome of HSV1. J. Mol. Biol. 181:1-13[CrossRef][Medline]. |
| 22. | McGeoch, D. J. 1992. Correlation between HSV-1 DNA sequence and viral transcription maps. In E. K. Wagner (ed.), Herpesvirus transcription and its regulation. CRC Press, Inc., Boca Raton, Fla. |
| 23. |
Neidhardt, H.,
C. H. Schroder, and H. C. Kaerner.
1987.
Herpes simplex virus type 1 glycoprotein E is not indispensable for viral infection.
J. Virol.
61:600-603 |
| 24. | Niikura, M., R. L. Witter, H-K Jang, M Ono, T Mikami, and R. F. Silva. 1999. MDV glycoprotein D is expressed in the feather follicle epithelium of infected chickens. Acta Virol. 43:159-163[Medline]. |
| 25. | Parcells, M. S., A. S. Anderson, and R. W. Morgan. 1994. Characterization of a Marek's disease virus mutant containing a LacZ insertion in the US6 (gD) homolog gene. Virus Genes 9:5-13[CrossRef][Medline]. |
| 26. |
Peeters, B.,
J. Pol,
A. Gielkens, and R. Moormann.
1993.
Envelope glycoprotein gp50 of pseudorabies virus is essential for virus entry but is not required for viral spread in mice.
J. Virol.
67:170-177 |
| 27. |
Petrovskis, E. A.,
A. L. Meyer, and L. E. Post.
1988.
Reduced yield of infectious pseudorabies virus and herpes simplex virus from cell lines producing viral glycoprotein gp50.
J. Virol.
62:2196-2199 |
| 28. |
Rauh, I., and T. C. Mettenleiter.
1991.
Pseudorabies virus glycoproteins gII and gp50 are essential for virus penetration.
J. Virol.
65:5348-5356 |
| 29. | Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, New York, N.Y. |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»